Objectives: In Canada, substance-related harms and mortality are a significant public health concern. Recently there have been discussions about the utility of involuntary hospital admissions for patients who have severe substance use disorders (SUDs) and may otherwise not receive or remain in treatment. This case report describes 3 patient cases where involuntary hospital admissions were used and resulted in good outcomes.Methods: Patients provided written informed consent to have their deidentified cases shared in this case report, and to review their electronic medical records for this purpose.Results: Patients ranged in age from early 20s to mid-50s. Each patient had a severe SUD and required inpatient hospitalization to stabilize. In each case, patients were admitted involuntarily to hospital for a brief period of time for safety and stabilization, permitting withdrawal management and initiation of medications to treat their SUDs. Although the patients were admitted involuntarily, they remained capable of consenting to treatment.Conclusions: When utilized for the least amount of time under specific circumstances, involuntary hospital admissions for people with severe SUDs may be productive and result in good outcomes for patients. Care should be taken to debrief involuntary admissions with patients to preserve therapeutic rapport. Future research should explore patient perspectives on involuntary hospitalization in the treatment of SUDs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.